Truvada Approved By FDA As First HIV-Prevention Pill

Source: Ryan Jaslow / CBS News

Truvada has been approved by the Food and Drug Administration as the first pill to prevent HIV.

Gilead Sciences’ Truvada has been taken by people over 12 with human immunodeficiency virus in conjunction with other antiretroviral drugs since it was first approved by the FDA in 2004. The new approval applies in combination with safer sex practices for preventative use in healthy individuals who are at a high risk for HIV or who may have sex with HIV-positive partners.

“Today’s approval marks an important milestone in our fight against HIV,”  FDA Commissioner Dr. Margaret A. Hamburg said in a press release. “Every year, about 50,000 U.S. adults and adolescents are diagnosed with HIV infection, despite the availability of prevention methods and strategies to educate, test, and care for people living with the disease. New treatments as well as prevention methods are needed to fight the HIV epidemic in this country.”

In the announcement, the FDA strongly recommended against Truvada’s use to prevent disease transmission in individuals who may already have HIV.

To read this article in its entirety visit CBS News.